Suppr超能文献

豚鼠回肠中调节乙酰胆碱从突触后毒蕈碱受体释放的突触前M1毒蕈碱受体的药理学差异

Pharmacological differentiation of presynaptic M1 muscarinic receptors modulating acetylcholine release from postsynaptic muscarinic receptors in guinea-pig ileum.

作者信息

Kawashima K, Fujimoto K, Suzuki T, Oohata H

机构信息

Department of Pharmacology, Kyoritsu College of Pharmacy, Tokyo, Japan.

出版信息

Gen Pharmacol. 1990;21(1):17-21. doi: 10.1016/0306-3623(90)90588-d.

Abstract
  1. Effects of three muscarinic antagonists on electrically evoked ACh release and contractile response were investigated in longitudinal muscle strips of guinea-pig ileum suspended in an organ-bath and superfused with Krebs solution. ACh release was determined by a specific radioimmunoassay. 2. Telenzepine, a selective M1 muscarinic antagonist, increased the ACh release at a concentration of 100-fold less than that inhibiting the contractile response (10 vs 1000 nM). 3. AF-DX 116, a cardioselective M2 muscarinic antagonist, inhibited the contractile response at 10 microM, but did not affect the ACh release at this concentration. 4. (-)N-Methylscopolamine (NMS) did not affect the ACh release, but inhibited the contractile response at all concentrations tested (1-1000 nM), indicating (-)NMS can be used as an ileal specific postsynaptic muscarinic antagonist. 5. These data demonstrate that presynaptic muscarinic receptors modulating ACh release are distinct from postsynaptic ones involved in the contractile response and can be classified as M1 subtype.
摘要
  1. 在置于器官浴槽中并用 Krebs 溶液灌流的豚鼠回肠纵行肌条上,研究了三种毒蕈碱拮抗剂对电诱发乙酰胆碱(ACh)释放及收缩反应的影响。ACh 释放通过特异性放射免疫测定法进行测定。2. 替仑西平,一种选择性 M1 毒蕈碱拮抗剂,在比抑制收缩反应浓度低 100 倍的浓度(10 对 1000 nM)时增加 ACh 释放。3. AF-DX 116,一种心脏选择性 M2 毒蕈碱拮抗剂,在 10 μM 时抑制收缩反应,但在此浓度下不影响 ACh 释放。4. (-)N-甲基东莨菪碱(NMS)不影响 ACh 释放,但在所有测试浓度(1 - 1000 nM)下均抑制收缩反应,表明(-)NMS 可作为回肠特异性突触后毒蕈碱拮抗剂。5. 这些数据表明,调节 ACh 释放的突触前毒蕈碱受体与参与收缩反应的突触后受体不同,且可归类为 M1 亚型。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验